Evidence map›Paper›PMID 38125295›Full record

ReviewFrontiers in allergy2023

Facial mask for prevention of allergic rhinitis symptoms.

Oğuzhan Oğuz, Felicia Manole, Nuray Bayar Muluk, Cemal Cingi

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Oğuzhan OğuzDepartment of Audiology, Health Services Vocational School, Istanbul Nişantaşı University, Istanbul, Türkiye.
Felicia ManoleDepartment of ENT, Faculty of Medicine, University of Oradea, Oradea, Romania.
Nuray Bayar MulukDepartment of Otorhinolaryngology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Türkiye.
Cemal CingiDepartment of Otorhinolaryngology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Türkiye.
Eskişehir Osmangazi University · TRİstanbul Nişantaşı Üniversitesi · TRKırıkkale University · TRUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We reviewed the role of facial masks in preventing allergic rhinitis (AR) symptoms. Methods: The literature survey was performed in PubMed, EBSCO, UpToDate, and Proquest Central databases of Kırıkkale University and Google and Google Scholar databases. Results: Aeroallergens are microscopic airborne particles that trigger AR symptoms. In sensitive people, the type 1 hypersensitivity reaction against these allergens occurs when these microparticles enter the nasal mucosa via inhalation. Pollens, molds, dust mites, and animal dander are only some of the allergens suspected of contributing to AR symptoms. The treatment guidelines for AR extensively encompass allergy avoidance and environmental management as the first-line treatment. It is recommended that those who experience seasonal symptoms try to avoid their triggers whenever possible. While medical masks filter out particles larger than 3 μm, FFP2 masks are effective against particles as small as 0.004 μm. Since both mask types are effective in filtering pollen larger than 5 μm in size, they can be used to prevent pollen exposure. The "antiviral protection" provided by medical and FFP2 masks to hospital employees is roughly equivalent. Thus, both should be effective against direct local (eye) or indirect inhaled (nose, bronchial) pollen exposure. For the masks to do their job, they need to fit correctly. Conclusion: Face mask affects AR patients' quality of life and reduces AR symptoms' severity.

Indexed as

aeroallergensallergic rhinitisface maskpreventionsymptoms

Identifiers

PMID38125295
PMCPMC10731048
OpenAlexW4389393148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.